Literature DB >> 32414739

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

George Goodchild1, Rory Jr Peters2, Tamsin N Cargill2, Harry Martin1, Adetokunbo Fadipe3, Maria Leandro1, Adam Bailey3, Jane Collier3, Louisa Firmin1, Manil Chouhan1, Manuel Rodriguez-Justo1, Ross Sadler3, Roger W Chapman2, Helen Bungay3, Eve Fryer3, Joel David3, Raashid Luqmani3, Eleanor Barnes2, George J Webster1, Emma L Culver4.   

Abstract

Immunoglobulin G4-related disease (IgG4-RD) is a complex multisystem fibro-inflammatory disorder, requiring diagnostic differentiation from malignancy and other immune-mediated conditions, and careful management to minimise glucocorticoid-induced toxicity and prevent progressive organ dysfunction. We describe the experience of the first inter-regional specialist IgG4-RD multidisciplinary team meeting (MDM) incorporating a broad range of generalists and specialists, held 6-weekly via web-link between Oxford University Hospitals NHS Foundation Trust and University College London Hospitals NHS Foundation Trust. Over 3 years, there were 206 discussions on 156 patients. Of these, 97 (62%) were considered to have definite or possible IgG4-RD; 67% had multi-organ involvement and 23% had a normal serum IgG4. The average number of specialist opinions sought prior to MDM was four per patient. Management was changed in the majority of patients (74%) with the treatment escalation recommended in 61 cases, including 19 for rituximab. Challenges arose from delays and misdiagnosis, cross-specialty presentation and the management of sub-clinical disease. Our cross-discipline IgG4-RD MDM enabled important diagnostic and management decisions in this complex multisystem disorder, and can be used as a model for other centres in the UK. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  IgG4-related disease; inflammation; multidisciplinary team; rituximab

Mesh:

Substances:

Year:  2020        PMID: 32414739      PMCID: PMC7354052          DOI: 10.7861/clinmed.2019-0457

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  30 in total

1.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Tadashi Yoshino; Shigeo Nakamura; Shigeyuki Kawa; Hideaki Hamano; Terumi Kamisawa; Toru Shimosegawa; Akira Shimatsu; Seiji Nakamura; Tetsuhide Ito; Kenji Notohara; Takayuki Sumida; Yoshiya Tanaka; Tsuneyo Mimori; Tsutomu Chiba; Michiaki Mishima; Toshifumi Hibi; Hirohito Tsubouchi; Kazuo Inui; Hirotaka Ohara
Journal:  Mod Rheumatol       Date:  2012-01-05       Impact factor: 3.023

Review 2.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

3.  Diagnosis of IgG4-related tubulointerstitial nephritis.

Authors:  Yassaman Raissian; Samih H Nasr; Christopher P Larsen; Robert B Colvin; Thomas C Smyrk; Naoki Takahashi; Ami Bhalodia; Aliyah R Sohani; Lizhi Zhang; Suresh Chari; Sanjeev Sethi; Mary E Fidler; Lynn D Cornell
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

Review 4.  Diagnostic criteria for IgG4-related ophthalmic disease.

Authors:  Hiroshi Goto; Masayuki Takahira; Masahiro Takahira; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

Review 5.  International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.

Authors:  A Khosroshahi; Z S Wallace; J L Crowe; T Akamizu; A Azumi; M N Carruthers; S T Chari; E Della-Torre; L Frulloni; H Goto; P A Hart; T Kamisawa; S Kawa; M Kawano; M H Kim; Y Kodama; K Kubota; M M Lerch; M Löhr; Y Masaki; S Matsui; T Mimori; S Nakamura; T Nakazawa; H Ohara; K Okazaki; J H Ryu; T Saeki; N Schleinitz; A Shimatsu; T Shimosegawa; H Takahashi; M Takahira; A Tanaka; M Topazian; H Umehara; G J Webster; T E Witzig; M Yamamoto; W Zhang; T Chiba; J H Stone
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

6.  Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis: An Analysis after Longterm Followup.

Authors:  Junpei Asano; Takayuki Watanabe; Takaya Oguchi; Keita Kanai; Masahiro Maruyama; Tetsuya Ito; Takashi Muraki; Hideaki Hamano; Norikazu Arakura; Akihiro Matsumoto; Shigeyuki Kawa
Journal:  J Rheumatol       Date:  2015-10-15       Impact factor: 4.666

7.  International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.

Authors:  Tooru Shimosegawa; Suresh T Chari; Luca Frulloni; Terumi Kamisawa; Shigeyuki Kawa; Mari Mino-Kenudson; Myung-Hwan Kim; Günter Klöppel; Markus M Lerch; Matthias Löhr; Kenji Notohara; Kazuichi Okazaki; Alexander Schneider; Lizhi Zhang
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

8.  Risk of malignancies in IgG4-related disease.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Tetsuya Tabeya; Chisako Suzuki; Yasuyoshi Naishiro; Keisuke Ishigami; Hidetaka Yajima; Yui Shimizu; Mikiko Obara; Hiroyuki Yamamoto; Tetsuo Himi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Mod Rheumatol       Date:  2011-09-06       Impact factor: 3.023

Review 9.  IgG4-related hepatobiliary disease: an overview.

Authors:  Emma L Culver; Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

Review 10.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.

Authors:  Zachary S Wallace; Ray P Naden; Suresh Chari; Hyon K Choi; Emanuel Della-Torre; Jean-Francois Dicaire; Phillip A Hart; Dai Inoue; Mitsuhiro Kawano; Arezou Khosroshahi; Marco Lanzillotta; Kazuichi Okazaki; Cory A Perugino; Amita Sharma; Takako Saeki; Nicolas Schleinitz; Naoki Takahashi; Hisanori Umehara; Yoh Zen; John H Stone
Journal:  Ann Rheum Dis       Date:  2019-12-03       Impact factor: 19.103

View more
  1 in total

1.  Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study.

Authors:  Giuseppe A Ramirez; Marco Lanzillotta; Mikael Ebbo; Andreu Fernandez-Codina; Gaia Mancuso; Olimpia Orozco-Galvez; Lorenzo Dagna; Nicolas Schleinitz; Fernando Martínez-Valle; Emma L Culver; Emanuel Della-Torre
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.